Eloxx Pharmaceuticals Statistics
NASDAQ: ELOXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
14.95+0.07 (+0.47%)
Market open · Delayed 15 min · as of Oct 8, 9:41 AM ET
Eloxx Pharmaceuticals by the numbers
Eloxx Pharmaceuticals has a market capitalization of $60.3 million based on 4.04M shares outstanding. Its trailing P/E ratio is 4.2. The stock trades 11.0% below its 50-day average and 0.2% below its 200-day average.
Average daily trading volume is 46.44K shares, or about $694,233 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ELOX valuation vs. peer median
| Metric | ELOX | Peer median | Difference |
|---|---|---|---|
| Market cap | $60.35M | $55.19M | +9% |
| Avg. volume | 46.44K | 13.51K | +244% |
Peer median across 8 companies: KLRS, INKT, CRBU, LONA, CSBR, BKHA, IMA, EXOZ.
Valuation
- Market cap
- $60.35M
- P/E (TTM)
- 4.25
- EPS (TTM)
- $3.52
- Shares outstanding
- 4.04M
Price and trading
- Previous close
- 14.88
- Open
- 14.67
- Day range
- 14.67 – 14.95
- 52-week range
- 8.20 – 23.40
- Beta
- —
- Volume
- 698
- Average volume
- 46.44K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Apr 2, 2025
Additional statistics
- Market Cap
- 60.35M
- Pe
- 4.25
- Forward Pe
- -21.06
- Eps
- 3.52
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 23.40
- Week52 Low
- 8.20
- Avg Volume
- 46,437.00
- Shares Outstanding
- 4.04M
- Ma50
- 16.79
- Ma200
- 14.98
- Earnings Date
- Apr 2, 2025
- Pct From52w High
- -36.11%
- Pct From52w Low
- 82.32%